Health
South African virus mutation raises questions over vaccine effectiveness – The Times of Israel
Scientists express concern over E484K strain, which Cambridge microbiologist warns ‘could be the start of problems for spike vaccines’ developed by Pfizer, Moderna…
PARIS (AFP) — As the British coronavirus variant occupies countries’ pandemic plans due to its increased transmissibility, other mutations to the Sars-CoV-2 are provoking concern among scientists who are scrambling to work out if they will respond to vaccines.
In particular, one mutation, known as E484K, detected initially in South Africa and on subsequent variants in Brazil and Japan, has raised alarm among researchers.
Ravi Gupta, professor of microbiology at the University of Cambridge, said…
-
Noosa News24 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Noosa News23 hours agoMeasles alert issued south of Brisbane after traveller tests positive
-
General22 hours agoArtists brace as AI, the greatest theft in history, swamps us now
-
General24 hours agoThe energy grid needs markets, not mandates!